Home » Topics » Regulatory

Regulatory
RSS

New antihistamine for pediatric patients in the U.S.

Oct. 11, 1996

First U.S. launch of product using Scherer's Zydis technology

Oct. 11, 1996

New use for Uriach's rupatadine

Oct. 11, 1996

New combination meningitis/hepatitis vaccine approved

Oct. 11, 1996

Fujisawa pursues new indications for tacrolimus

Oct. 11, 1996

IND filed for MiKasome

Oct. 11, 1996

Roche and Gilead Sciences to copromote hepatitis treatment in the U.S.

Oct. 4, 1996

Joint venture formed for development of oral heparin

Oct. 4, 1996

Schering-Plough seeks approval for corticosteroid nasal spray in rhinitis

Oct. 4, 1996

Atypical antipsychotic receives approvals

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 12, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...